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 2 
Abstract 22 
Facing a bottleneck in the growth of aquaculture, and a gap in the supply and demand of the 23 
highly beneficial omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFA), 24 
sustainable alternatives to traditional marine–based feeds are required. Therefore, in the 25 
present trial, a novel oil obtained from a genetically engineered oilseed crop, Camelina 26 
sativa, that supplied over 25 % n-3 LC-PUFA was tested as a sole dietary added lipid source 27 
in Atlantic salmon (Salmo salar) feed. Three groups of fish were fed for 12 weeks three 28 
experimental diets with the same basal composition and containing 20 % added oil supplied 29 
by either a blend of fish oil and rapeseed oil (1:3) (COM) reflecting current commercial 30 
formulations, wild-type Camelina oil (WCO) or the novel transgenic Camelina oil (TCO). 31 
There were no negative effects on the growth, survival rate or health of the fish. The whole 32 
fish and flesh n-3 LC-PUFA levels were highest in fish fed TCO with levels almost and more 33 
than 2-fold higher compared to those of fish fed the COM and WCO diets, respectively. Diet 34 
TCO had no negative impacts on the evaluated immune and physiological parameters of head 35 
kidney monocytes. The transcriptomic responses of liver and mid-intestine showed only mild 36 
effects on metabolism genes. Overall, the results clearly indicated that the oil from transgenic 37 
Camelina was highly efficient in supplying n-3 LC-PUFA providing levels double that 38 
obtained with a current commercial standard, and similar to those a decade ago prior to 39 
substantial dietary fishmeal and oil replacement.  40 
  41 
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1. Introduction 42 
Fish is recognized as a nutritious and healthy food in part due to the fact that they are 43 
naturally rich in the health promoting omega-3 (n-3) long-chain polyunsaturated fatty acids 44 
(LC-PUFA), eicosapentaenoic acid (20:5n-3; EPA) and docosahexaenoic acid (22:6n-3; 45 
DHA)
(1,2)
. Much of the fish consumed today is farmed
(3)
, many reared on feeds containing 46 
high levels of more sustainable raw materials such as plant meals and oils of agricultural 47 
origin. Such terrestrial ingredients are devoid of n-3 LC-PUFA and, therefore, the use of 48 
these plant ingredients translates into reduced levels of beneficial n-3 LC-PUFA in the fillet 49 
of the fish, as has been documented in farmed Atlantic salmon (Salmo salar) from 2006 50 
onwards
(4)
. This means that larger or more portions of farmed fish must be consumed in order 51 
to obtain the recommended EPA and DHA intake suggested by different agencies (e.g. 5 and 52 
6).  53 
      Oilseed crops are major agricultural products with a highly organised and well-54 
established infrastructure for their cultivation, harvest, and processing, as well as distribution, 55 
marketing and utilisation of vegetable oils (VO)
(7)
. Thus, VO have been the main alternatives 56 
to dietary fish oil (FO) in aquafeeds and, while these oils are devoid of n-3 LC-PUFA, they 57 
can be rich in shorter chain PUFA such as 18:3n-3. This opens up the possibility for genetic 58 
modification to enable the desaturation and elongation of 18:3n-3 to EPA and DHA. 59 
Recently, transgenic Camelina sativa crops, capable of producing either EPA or EPA and 60 
DHA in their seeds, have been developed
(8,9)
. Two such oils have been evaluated as 61 
replacements for dietary FO in feeds for Atlantic salmon (Salmo salar)
(10-13) 
 and gilthead sea 62 
bream (Sparus aurata)
(14) 
showing promising results, enabling good fish growth and 63 
deposition of n-3 LC-PUFA in tissues including flesh. In contrast, feeds formulated with high 64 
levels of conventional plant ingredients, including VO, can adversely affect fish health 65 
through impacts on immune and stress responses
(15)
. A well-balanced dietary fatty acid 66 
profile, particularly in terms of LC-PUFA, is a determinant of animal health and welfare and, 67 
thus, the replacement of FO by VO can alter this balance. In previous trials, no major impacts 68 
on fish health were observed after feeding fish with oil from transgenic Camelina supplying 69 
12% EPA+DHA with, specifically, no detrimental effects on immune function
(12)
 or response 70 
after an environmental stress
(13)
. However, the outcome of stress responses in fish fed VO 71 
will depend on the intensity and type of the stressor as well as its duration
(16)
 and, therefore, 72 
different stressors may have different effects on particular immune or inflammatory 73 
responses.  74 
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   In previous studies, oils from transgenic Camelina supplying either 20% EPA or 6% each 75 
of EPA and DHA were tested in Atlantic salmon against “gold standard” feeds formulated 76 
with high fishmeal and FO
(10-12)
. The oil supplying 6% each of EPA and DHA was 77 
subsequently tested in Atlantic salmon against feeds formulated with lower fishmeal and 78 
FO
(13)
. In the present study, a third generation oil supplying levels of EPA, DHA and total n-3 79 
LC-PUFA greater than most FO was tested in feeds for Atlantic salmon with even lower 80 
levels of fishmeal and FO reflecting current commercial salmon feeds. Thus, triplicate groups 81 
of Atlantic salmon were fed one of three experimental diets formulated with 30 % fishmeal 82 
and 43 % plant meals that contained either a mix of FO and rapeseed oil (1:3) (diet COM), 83 
wild-type Camelina oil (diet WCO) or transgenic Camelina oil (diet TCO) in order to 84 
evaluate the capability of the new transgenic oil to restore EPA and DHA levels in farmed 85 
salmon to those of a decade ago before the development of sustainable feeds
(4)
. Therefore, 86 
feeds were formulated with lower levels of fishmeal (30 % vs. 49 or 35 % previously) and, in 87 
the reference (COM) diet, FO (5 % vs. 17.5 or 10 % previously) to reflect current feed 88 
formulations and n-3 LC-PUFA levels. The impacts of diet TCO on fish growth performance 89 
and tissue fatty acid composition were assessed, and influences on fish metabolism were 90 
determined by investigating gene expression via liver and pyloric caeca (PC) transcriptomic 91 
responses. Additionally, at the end of the experimental trial an ex vivo challenge was 92 
performed on head kidney monocytes in order to assess potential impacts on the immune 93 
response. 94 
 95 
 96 
  97 
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2. Materials and Methods 98 
2.1 Diets and feeding trial 99 
The feeding trial was carried out at the facilities of the Institute of Marine Research (Matre, 100 
Norway) from December 2016 to February 2017. A total of 297 post-smolt Atlantic salmon 101 
(initial weight 133.0 ± 1.6) were distributed into nine 400 L squared flow-through seawater 102 
tanks (33 fish per tank) and fed twice daily with one of the three feeds in triplicate for 12 103 
weeks. Fish were fed to satiety+ to ensure that feed availability did not restrict growth. Water 104 
temperature was maintained at 13 °C throughout the experimental period. The three feeds 105 
were formulated to be essentially isonitrogenous and isolipidic and produced by vacuum 106 
coating identical basal extruded pellets with either FO/rapeseed oil (COM), wild-type 107 
Camelina oil (WCO) or high EPA+DHA-Camelina oil (TCO) (Table 1). Fatty acid profiles of 108 
the constituent oils used in the present trial (Supplementary Table 1) resulted in percentages 109 
of both EPA and DHA in diet TCO that were almost 3-fold higher than in the other two 110 
dietary treatments (Table 1). The proportions of n-6 and total PUFA were also higher in the 111 
TCO diet whereas this feed showed the lowest levels of monounsaturated fatty acids. Yttrium 112 
oxide (Y2O3, >99.9 % purity, Strem chemicals, Bischheim, France) was added to the feeds as 113 
an inert marker in order to determine lipid and fatty acid digestibility. All procedures were 114 
approved by the Norwegian Animal Experiment Committee (Forsøksdyrutvalget), 115 
experiment ID.8089. 116 
 117 
2.2 Sample collection 118 
At the end of the feeding trial 13 fish per tank were killed by an overdose of metacaine 119 
sulphonate (> 150 mg l
-1
, FINQUEL vet., ScanAqua AS, Årnes, Norway). Fish were 120 
measured (weight and length) and blood from 4 fish per tank collected via the caudal vein 121 
using 1 ml heparinised syringes fitted with 20G needles, and whole blood used for 122 
haematocrit determination. Two whole fish per tank were frozen (-20 °C) for biochemical 123 
proximate composition analysis, and liver and pyloric caeca were collected from 4 fish per 124 
tank were stabilized in RNA Later (Sigma, Poole, UK) and frozen at -20 °C until further 125 
RNA extraction. After sampling the fish remaining in the tanks continued to be fed the same 126 
feeds as prior to sampling for a further three days at which point faeces were collected and 127 
pooled by tank (n = 3). Briefly, fish were killed by an overdose of metacaine sulphonate as 128 
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above and faecal samples collected from the hind gut region by gently squeezing the ventral 129 
abdominal area
(17)
. Faeces were initially stored at -20 °C and freeze dried prior to analyses.  130 
2.3 Proximate composition 131 
Feeds were ground and whole fish were pooled per tank (n = 3 per dietary treatment) and 132 
homogenised before determination of proximate composition according to standard 133 
procedures
(18)
. Moisture contents were obtained after drying in an oven for 24 h at 110 °C. 134 
Ash content was determined after incinerating the samples at a temperature of 600 °C for 20 135 
h. Crude protein content was measured by determining nitrogen content (N x 6.25) using 136 
automated Kjeldahl analysis (Tecator Kjeltec Auto 1030 analyzer, Foss, Warrington, UK) 137 
and crude lipid determined gravimetically after Soxhlet lipid extraction with petroleum ether 138 
(Fisher Scientific UK, Loughborough) using a Tecator Soxtec system 2050 Auto Extraction 139 
apparatus (Foss, Warrington, UK).  140 
2.4 Calculations 141 
Biometric parameters were estimated as follows: Fulton’s condition factor (k) = 100 * 142 
(W/L
3
), where W is the final weight (g) and L is the total length (cm). Specific growth rate 143 
(SGR) = 100 * (lnWo – ln Wf) * D-1, where Wo and Wf are the initial and final weights 144 
(tanks means, n = 3), respectively, and D represents the number of feeding days.  145 
2.5 Lipid content and fatty acid composition  146 
Total lipid was extracted from feeds, faeces and whole fish, and flesh, liver, head kidney, 147 
midgut, and hindgut homogenates prepared from three pooled fish per tank (n = 3 per 148 
treatment) by homogenising approximately 1 g samples in chloroform/methanol (2:1, v/v) 149 
using an Ultra-Turrax tissue disrupter (Fisher Scientific, Loughborough, UK), with content 150 
determined gravimetrically
(19)
. Fatty acid methyl esters (FAME) were prepared from total 151 
lipid by acid-catalysed transesterification at 50 ˚C for 16 h(20), and FAME extracted and 152 
quantified by a gas chromatography (AutoSystem XL, Perkin Elmer, Waltham, MA) with 153 
Total Chrom Version 6.3.1 software. The GC was equipped with a fused silica capillary 154 
column coated with chemically-bonded polyethylene glycol (CP-Wax 52CB, 25 m × 0.25 155 
mm i.d; Varian, Palo Alto, CA), auto-injector (1 µl, inlet temperature 250 ºC) and a flame 156 
ionisation detector (FID, 280 ºC). Helium was the carrier gas and the oven temperature 157 
program was 90 ºC for 1 min, increased to 150 ºC at 30 min
-1
 and finally raised to 225 ºC at 3 158 
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ºC min
-1
 and held for 7 min.. Individual methyl esters were identified by comparison with 159 
known standards and a well-characterised fish oil, and also by reference to published data
(21)
. 160 
2.6 Digestibility calculation: 161 
The apparent digestibility coefficients (ADC) of lipid and selected fatty acids were calculated 162 
as: 100 – [100 x (Y2O3 concentration in feed/Y2O3 concentration in faeces) x (lipid or fatty 163 
acid concentration in faeces/lipid or fatty acid concentration in feed)]. The concentration of 164 
individual fatty acids in diets and faeces were calculated based on the relative proportion of 165 
each fatty acid compared with a known amount of internal standard (17:0) added and the total 166 
lipid content determined in the samples.    167 
2.7 Isolation and primary culture of head kidney monocytes/macrophages  168 
Four fish per tank were killed by an overdose of metacaine sulphonate (as above) and head 169 
kidneys removed, pooled (n = 2 per tank) and transferred to Leibovitz L-15 medium (Sigma, 170 
Oslo, Norway) supplemented with 10 U ml
-1
 heparin, 1.8 mM glucose, 10 mM HEPES, 20 U 171 
Penicillin ml
−1, 20 μg Streptomycin ml−1 and 0.05 μg Amphotericin B ml−1. Head kidneys 172 
were carefully sieved through a 100 m nylon cell strainer and the cell suspension loaded 173 
onto discontinuous 36 % / 54 % Percoll (GE Healthcare, Oslo, Norway) gradients followed 174 
by centrifugation at 400 g for 30 min at 4 °C. The interface was collected and washed twice 175 
with L-15 medium (without heparin) followed by centrifugation at 400 g for 5 min at 4 °C. 176 
Finally, cells were diluted in L-15 medium and seeded at a density of 1 × 10
7
 cells per well in 177 
96-well or 6-well culture plates (Nunc, Roskile, Denmark) in aliquots of 50 μl well-1 or 1 ml 178 
well
-1
, respectively. The culture plates were incubated at 12 °C overnight and the cells 179 
washed twice in 50 ml L-15 and incubated in L-15 for further studies. 180 
2.8 LPS challenge 181 
Isolated macrophage cultures (6-well plates; n = 6) were stimulated with 20 μg ml-1 crude E. 182 
coli LPS (0111:B4; Sigma Aldrich, Oslo, Norway). Samples were collected prior to the 183 
addition of LPS (0 h) and after incubation at 12 °C for sequential sampling points (6 and 24 184 
h) cells were harvested by adding 1 ml of TRI Reagent
®
 (Sigma, Oslo, Norway) lysis buffer 185 
and stored at -70 °C until RNA extraction.  186 
2.9 Respiratory burst activity 187 
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Respiratory burst activity was determined by the reduction of nitroblue tetrazolium (NBT) to 188 
formazan
(22,23)
 Cells were incubated in L-15 medium supplemented with 1 mg ml
-1
 NBT and 189 
1 µg ml
-1
 phorbol myristate acetate (PMA) for 30 min at 12 °C. Cells were then washed twice 190 
with pre-warmed phosphate-buffered saline (PBS) and fixed in absolute methanol for 10 min, 191 
washed once with 70 % methanol to remove extracellular formazan, air-dried and then 192 
intracellular formazan was dissolved in 120 µl 2 M KOH and 140 µl DMSO. Absorbance 193 
was measured in a microplate reader at 630 nm using a KOH/DMSO blank. The mean 194 
number of cells, obtained from at least three wells was determined by counting nuclei after 195 
removal of medium and addition of 100 µl lysis buffer containing 0.1 M citric acid, 1 % 196 
Tween 20 and 0.05 % crystal violet. Results were presented as absorbance per 10
5
 cells. 197 
2.10 Phagocytosis 198 
Phagocytic activity was determined by a modification of the method of Pulsford et al.
(24) 
199 
using opsonised yeast as engulfed material. For opsonisation, yeast was sterilized in boiling 200 
water and, after several washes with PBS, yeast were incubated overnight with foetal bovine 201 
serum (FBS) at room temperature
(25)
. Head kidney cells were mixed with opsonised yeast to 202 
obtain an approximate ratio of 10:1 yeast to kidney cells. Phagocytosis proceeded for 1 h at 203 
26 °C, and was then terminated by washing with ice-cold PBS. Phagocytosis was evaluated 204 
by observation by inverted light microscopy
(26)
. At least one hundred cells were counted and 205 
phagocytosis was expressed as Phagocytosis percentage (PP), which was calculated: 206 
𝑃𝑃 = (
𝑛𝑜 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑖𝑛𝑔𝑒𝑠𝑡𝑖𝑛𝑔 𝑦𝑒𝑎𝑠𝑡𝑠
𝑛𝑜 𝑜𝑓 𝑎𝑑ℎ𝑒𝑟𝑒𝑛𝑡 𝑐𝑒𝑙𝑙𝑠 𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑
) × (
𝑛𝑜 𝑜𝑓 𝑦𝑒𝑎𝑠𝑡 𝑖𝑛𝑔𝑒𝑠𝑡𝑒𝑑
𝑛𝑜 𝑜𝑓 𝑎𝑑ℎ𝑒𝑟𝑒𝑛𝑡 𝑐𝑒𝑙𝑙𝑠 𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑
) 
 207 
2.11 RNA extraction and cDNA synthesis 208 
Individual liver and pyloric caeca samples from eighteen fish per dietary treatment were 209 
homogenised in 1 ml of TriReagent
®
 (Sigma-Aldrich, Dorset, UK) to extract total RNA 210 
following the producer’s protocol. Quantity and quality of RNA was determined by 211 
spectrophometry using a Nanodrop ND-1000 (Labtech Int., East Sussex, UK). The same 212 
protocol was used to extract RNA from macrophage samples. cDNA was synthesised using a 213 
high capacity reverse transcription kit utilising 2 μg of total RNA and random primers in a 214 
total reaction volume of 20 μl following the manufacturer’s protocol (Applied Biosystems, 215 
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Warrington, UK). The samples were pooled to obtain n = 6 per dietary treatment. A dilution 216 
of 1:20 was applied to the resulting cDNA using milliQ water. 217 
2.12 Liver and pyloric caeca transcriptome - microarray hybridisations and image analysis 218 
Transcriptomic analysis of liver and pyloric caeca was performed using a custom-designed 4 219 
x 44 k Atlantic salmon oligo microarray (Agilent Technologies, Wokingham, UK; 220 
ArrayExpress accession no. A-MEXP-2065). The salmon microarray and laboratory 221 
procedures utilised have been widely used and validated in many previous studies
(10-11; 27-30)
. 222 
Replicate RNA samples were amplified using TargetAmp™ 1-Round Aminoallyl-aRNA 223 
Amplification Kit, (Epicentre Technologies Corporation, Madison, Wisconsin, USA) 224 
following recommended procedures. Aminoallyl-amplified RNA (aRNA) samples were 225 
labelled with Cy3 dye (GE HealthCare Life Sciences, Buckinghamshire, UK) while a pool of 226 
all aRNA samples was labelled with Cy5 dye (GE HealthCare Life Sciences) and used as a 227 
common reference in a dual-label common reference design, and finally hybridised. Scanning 228 
was performed using a GenePix 4200 AL Scanner (Molecular Devices (UK) Ltd., 229 
Wokingham, UK), and the resulting images analysed with Agilent Feature Extraction 230 
Software v.9.5 (Agilent Technologies) to extract intensity values and identify features. 231 
Features considered outliers (i.e., defined as those probes whose background intensity was 232 
between the 0.05
th
 and 99.95
th
 percentile of the distribution) in two or more replicates within 233 
at least one treatment were excluded from further analyses. Additionally, features 234 
consistently expressed just above background noise (defined as those features whose intensity 235 
was lower than the 5
th
 percentile of the distribution in 75 % or more of the analysed samples) 236 
were also removed. The full protocol for microarray and data analysis has been reported 237 
previously
(10)
. The full data set supporting the results is available in MIAME-compliant 238 
format in the ArrayExpress repository under accession number E-MTAB-6228. 239 
2.13 Quantitative PCR gene expression 240 
Gene expression levels were determined by real-time quantitative RT-PCR in liver, pyloric 241 
caeca and macrophages as described previously
(31)
. Genes involved in LC-PUFA biosynthesis 242 
(fads2d6, delta-6 fatty acyl desaturase; fads2d5, delta-5 fatty acyl desaturase; elovl2, fatty 243 
acyl elongase 2; elovl5a, fatty acyl elongase 5 isoform a; elovl5b, fatty acyl elongase isoform 244 
b) were measured in liver and pyloric caeca whereas genes involved in inflammation (il1b, 245 
interleukin 1 beta; cox2, cyclooxygenase 2, inos, inducible nitric oxide synthase and tnfα, 246 
tumor necrosis factor alpha;) and antibacterial activity (cath, cathelicidin and hepc, hepcidin) 247 
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were measured in macrophages (Supplementary Table 2). Results were normalised using 248 
reference genes, cofilin 2 (cfl2), elongation factor 1 alpha (ef1α) and ribosomal protein L2 249 
(rpl2). Primers were designed using Primer 3 in regions that included the microarray 250 
probes
(32)
. Quantitative PCR was performed using a Biometra TOptical Thermocycler 251 
(Analytik Jena, Goettingen, Germany) in 96-well plates in duplicate 20 μl reaction volumes 252 
containing 10 μl of Luminaris Color HiGreen qPCR Master Mix (Thermo Scientific), 1 μl of 253 
primer corresponding to the analysed gene (10 pmol), 3 μl of molecular biology grade water 254 
and 5 μl of cDNA, with the exception of the reference genes, which were determined using 2 255 
μl of cDNA. In addition, amplifications were carried out with a systematic negative control 256 
(NTC-no template control) containing no cDNA. Standard amplification parameters 257 
contained an UDG pre-treatment at 50 °C for 2 min, an initial activation step at 95 °C for 10 258 
min, followed by 35 cycles: 15 s at 95 °C, 30 s at the annealing Tm and 30 s at 72 °C.  259 
2.12 Statistical Analysis: 260 
All data are means ± S.D. (n = 3) unless otherwise specified. Percentage data were subjected 261 
to arcsin square-root transformation prior to statistical analyses. Data were tested for 262 
normality and homogeneity of variances with Levene’s test prior to one-way analysis of 263 
variance (ANOVA) followed by a Tukey and post-hoc test. All statistical analyses including 264 
the gene expression results were performed using SPSS software (IBM SPSS Statistics 23; 265 
SPSS Inc., Chicago, IL, USA).   266 
 267 
3. Results 268 
3.1 Fish growth performance and biochemical composition  269 
No significant differences were observed between the three dietary groups at the end of the 270 
feeding period in any of the evaluated growth or biometric parameters (Table 2). There was a 271 
100 % survival rate and no presence of disease was observed. Fish fed diet TCO had a lower 272 
lipid content than fish fed the COM and WCO diets, but there were no differences in protein, 273 
ash or dry matter contents of whole fish (Table 2). 274 
 275 
3.2 Lipid and fatty acid digestibility 276 
Differences in apparent digestibility coefficient (ADC) of dietary lipid were observed among 277 
the dietary treatments with TCO showing the lowest value (Table 3). The ADCs of saturated 278 
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and monounsaturated fatty acids varied between about 87 - 94 % and 91 – 98 %, respectively, 279 
with the rank order generally being COM > WCO > TCO (Table 3). The ADC for n-6, n-3 280 
and total PUFA were all 97 - 98 % with few significant differences between feeds although 281 
the diet WCO showed the lowest ADC for EPA, DHA, 22:5n-3 (docosapentaenoic acid, 282 
DPA) and 20:4n-6 (arachidonic acid, ARA). The COM diet showed the lowest ADC for 283 
20:3n-3, probably reflecting the very low dietary content of this fatty acid (Table 1).  284 
 285 
3.3 Lipid contents and fatty acid compositions of whole fish and tissues 286 
The lower lipid content of whole fish fed diet TCO compared to fish fed COM (Table 2) was 287 
reflected in the lipid content of flesh (whole muscle) although there was no significant 288 
difference to fish fed WCO (Table 4). In contrast, diet had no effect on the lipid contents of 289 
liver and head kidney (Table 5).   290 
 291 
3.4 Fatty acid compositions of whole fish and tissues 292 
The proportion of total n-3 LC-PUFA in whole body of Atlantic salmon fed diet TCO was 293 
around double that of fish fed diets WCO or COM (Table 4). Specifically, the relative 294 
contents of EPA, DPA and DHA were highest in fish fed TCO with fish fed COM and WCO 295 
showing similar lower values. The proportions of 18:2n-6, ARA and n-6 PUFA were also 296 
highest in TCO-fed fish with COM-fed fish showing the lowest proportions of 18:2n-6 and 297 
total n-6 PUFA. Differences were also observed in total saturated and monoenes with COM-298 
fed fish showing the lowest and highest contents respectively.  299 
    Flesh of fish fed TCO displayed the highest contents of the n-3 LC-PUFA, EPA, DPA and 300 
DHA, and ARA (Table 4). In COM-fed fish, flesh showed the highest proportions of total 301 
saturates and 18:1n-9, and the lowest contents of 18:3n-3, whereas WCO-fed fish contained 302 
the highest percentage of this fatty acid. Relative levels of total n-3 PUFA, EPA and DPA in 303 
liver and head kidney were highest in fish fed TCO, although total n-3 LC-PUFA levels in 304 
TCO-fed fish was not different to WCO-fed fish. Although DHA level was highest in fish fed 305 
TCO in both liver and head kidney, variation in the data rendered the dietary differences not 306 
significant (Table 5). 307 
    A PCA analysis was applied to the whole fish and tissue fatty acid profiles (percentage) of 308 
fish fed the three experimental feeds. The first two principal components explained 82.8 % of 309 
variance (Fig. 1). The score plot showed some separation between tissues of fish fed COM 310 
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and those fed both WCO and TCO. There was an overlap between tissues of fish fed WCO 311 
and TCO, although liver from fish fed TCO showed a distinct profile, clustering at the left 312 
side of the plot (red diamonds). The fatty acid vectors representing the MUFA 16:1n-7, 313 
18:1n-7, 18:1n-9 and 22:1n-11 appeared to be correlated with fish fed the COM diet. The n-6 314 
and n-3 PUFA (18:2n-6, 18-3n-3 and 18:4n-3) vectors lie towards fish fed WCO whereas the 315 
n-6 and n-3 LC-PUFA (20:4n-6, 20:5n-3, and 22:6n-3) point towards TCO-fed fish, as well 316 
as livers from WCO-fed fish.  317 
 318 
3.5 Liver transcriptome 319 
In liver, a total of 312 unique genes were differentially expressed (p ˂ 0.05; fold-change, FC 320 
˃ 1.3) in salmon fed the TCO diet versus the COM diet whereas 249 genes were affected 321 
when comparing WCO-fed fish with COM-fed fish (Table 6). The highest number (506) of 322 
differentially expressed genes (DEG) was observed when comparing the hepatic 323 
transcriptomes of TCO-fed and WCO-fed fish. Among these unique probes, 86 DEG were 324 
commonly regulated when comparing fish fed TCO with fish fed either COM or WCO, 325 
whereas 45 were found when TCO- and WCO-fed fish were compared to COM-fed fish and 326 
only 37 when fish fed TCO and COM were compared to those fed WCO (Fig. 2A).  327 
        In order to elucidate the genes exclusively affected by TCO, KEGG Orthology (KO) 328 
numbers were assigned to the 86 genes commonly affected by TCO (Supplementary Table 3), 329 
and genes mapped to a known compendium of metabolic pathways (KEGG). Enrichr, an 330 
integrative web-based software application
(33)
, was used to build a network with the enriched 331 
gene sets (Fig. 3A). Many of the categories represented belonged to metabolism with high 332 
representation of lipid metabolism including “fatty acid degradation”, “sphingolipid 333 
metabolism” and “terpenoid backbone biosynthesis”, as well as amino acid metabolism 334 
including “alanine, aspartate and glutamate metabolism” and “other glycan degradation”. 335 
Genes belonging to other categories such as “protein processing in the endoplasmic 336 
reticulum”, and “DNA replication” were also highly represented. At a gene level, all the 337 
genes presented the same direction of regulation (up or down) between both contrasts and a 338 
similar FC. Expression of a set of candidate LC-PUFA biosynthesis genes was determined by 339 
qPCR with fads2d5 and fads2d6 showing up-regulation in fish fed WCO, with no difference 340 
between fish fed TCO and COM (Fig. 4). No differences were observed among the 341 
expression of the other LC-PUFA biosynthesis genes evaluated by qPCR. 342 
 343 
3.6 Pyloric caeca transcriptome  344 
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A greater number of DEG was found in pyloric caeca compared to liver when comparing fish 345 
fed either diets TCO or WCO to fish fed COM (804 and 971 DEG, respectively) (Table 6). 346 
However when comparing fish fed TCO with fish fed WCO, the number of DEG was much 347 
lower in pyloric caeca compared to liver (279 versus 506). There were differences in the 348 
distribution of genes depending on FC, with a high number of DEG showing FC >2.5, 349 
particularly among down-regulated genes. 350 
        Only 61 genes were commonly regulated in the pyloric caeca of fish fed TCO compared 351 
with fish fed COM and WCO (Fig. 2B). Network analysis of the enriched categories showed 352 
that most of the genes were related to metabolism, although many also belonged to “mTOR 353 
signalling pathway” and “regulation of autophagy” (Fig. 3B). After removing non-annotated 354 
genes, 24 unique genes could be identified as being commonly affected by TCO in pyloric 355 
caeca (Supplementary Table 4). All the genes presented the same direction of regulation and 356 
similar FC in both contrasts (TCO v. COM and TCO v. WCO). High FCs were observed 357 
particularly in genes related to carbohydrate metabolism (N-acetylgalactosaminide alpha-2,6-358 
sialyltransferase and beta-mannosidase), which were up-regulated in TCO-fed fish, 359 
particularly when compared with WCO-fed fish (FC of 12.7 and 6.8, respectively). In pyloric 360 
caeca, while there appeared to be a trend for lower expression of most of the LC-PUFA 361 
biosynthesis genes in fish fed TCO compared to fish fed COM, but this was only significant 362 
with elovl5b (Fig. 5).  363 
 364 
3.7 Head kidney cell LPS challenge and gene expression  365 
Diet did not significantly affect leucocyte respiratory burst activity, although there was a 366 
trend toward lower values in TCO-fed fish (p = 0.057; Table 7). Similarly, no differences 367 
were observed in phagocytic activity of monocytes/macrophages from fish fed the three 368 
dietary treatments (p = 0.854; Table 7).  369 
      Atlantic salmon monocytes were exposed to LPS to study the effect on gene expression at 370 
0, 6 and 24 h after addition. The exposure to LPS triggered a response in all of the genes 371 
evaluated with highest expression levels observed 24 h after application of the challenge (Fig. 372 
6). The FC varied among the studied genes, with the strongest regulation in cox2 (approx. 373 
2500 FC) and the lowest in inos (approx. 4 FC). Two-way ANOVA showed gene expression 374 
was highly affected by sampling time (p < 0.001), but diet did not affect expression of any of 375 
the studied genes and there was no interaction between diet and sample time. 376 
 377 
Discussion 378 
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The benefits of n-3 LC-PUFA on several aspects of human health are widely known and 379 
appreciated (Calder, 2017). However, recent studies have highlighted the gradual decrease of 380 
these essential fatty acids in the flesh of farmed salmon, reflecting the necessary development 381 
of sustainable feeds increasingly formulated with lower levels of marine ingredients that 382 
supply the n-3 LC-PUFA
(4)
. Previous studies demonstrated the feasibility of oils obtained de 383 
novo from transgenic Camelina sativa to supply n-3 LC-PUFA in feeds for Atlantic salmon 384 
and sea bream, maintaining growth and enhancing n-3 LC-PUFA contents in fillet compared 385 
to fish reared on feeds formulated with conventional VO
(10-14)
. The earlier oils from 386 
transgenic Camelina supplied either 20 % EPA or 6 % each of EPA and DHA and were 387 
compared to feeds formulated with high fishmeal and FO as “gold standards”(10-12,14) and also 388 
a feed with lower fishmeal and FO
(13)
. In the present study, the latest generation of transgenic 389 
oil supplied levels of EPA, DHA and total n-3 LC-PUFA as high as many FO, or higher than 390 
those from the northern hemisphere, and was specifically tested in order to evaluate its 391 
capability to maintain the sustainability of feeds while simultaneously restoring levels of n-3 392 
LC-PUFA in farmed salmon to those of a decade ago, before the development of low marine 393 
feeds
(4)
.  394 
      In the present study, the COM diet was formulated to reflect current commercial feed 395 
formulations for salmon and thus included levels of fishmeal and FO that resulted in a dietary 396 
n-3 LC-PUFA level of around 7 % of total dietary fatty acids. Replacing the added oil with 397 
the oil from transgenic Camelina resulted in the n-3 LC-PUFA content of the TCO diet being 398 
almost 24 % of total fatty acids that, in turn, almost doubled the EPA+DHA and n-3 LC-399 
PUFA contents of flesh of the TCO-fed fish compared to fish fed the COM diet. While the 400 
fish in the present trial were not market size and so the data obtained are not directly 401 
comparable to the data presented in (4), they nonetheless indicate the potential of this 3
rd
 402 
generation transgenically-derived oil to supply sufficient n-3 LC-PUFA to restore EPA+DHA 403 
levels in farmed salmon to levels last seen a decade ago, thus retaining all the positive health 404 
benefits associated with the consumption of fish.  405 
   As in previous trials, no differences in term of growth were observed between fish fed the 406 
different feeds, which was not unexpected given that the levels of n-3 LC-PUFA contained in 407 
all the feeds were sufficient to cover the requirements for this species. For instance, total n-3 408 
LC-PUFA in fish fed diet WCO was still ~5.5 % of total fatty acids representing ~ 1.1 % of 409 
diet, already above the reported EFA requirement level without even considering the high 410 
dietary level of 18:3n-3
(34)
. In agreement with previous trials, Atlantic salmon fed TCO 411 
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showed a reduced deposition of lipid in whole body and flesh, and, although not always 412 
significant, other tissues
(12)
, which could be attributed to the higher contents of EPA and 413 
DHA that are known to have anti-adipogenic effects in mammals
(35)
. Additionally, the 414 
microarray revealed that acsl, a gene involved in lipid biosynthesis, was commonly down-415 
regulated in TCO-fed fish when compared to fish fed COM or WCO, which could indicate 416 
inhibition of lipogenesis. Interestingly, the expression of lpl was also down-regulated in 417 
TCO-fed fish, which may or may not be consistent with lower lipid levels in tissues. 418 
However, at least three different transcripts exist for lpl in Atlantic salmon and different 419 
patterns of nutritional regulation for each isoform have been demonstrated
(36)
.  420 
    Although there were no effects on growth performance, some differences were observed in 421 
lipid and fatty acid digestibility. The ADC for lipid was generally high and affected by 422 
dietary lipid source, being slightly higher in the COM and WCO feeds than in TCO feed. 423 
Previous studies in several teleost species generally reported highest lipid ADC in feeds 424 
containing FO
(37,38)
. Indeed, in our previous studies, feeds for Atlantic salmon formulated 425 
with either wild-type or transgenic Camelina oil displayed higher lipid ADC than feeds 426 
containing FO
(11,12)
. However the FO-based feeds were formulated with high levels of 427 
fishmeal (49 %) and FO (18 %) and thus the content of n-3 LC-PUFA was much higher than 428 
in the VO-based feeds, whereas in the present trial diet TCO contained the highest contents of 429 
n-3 LC-PUFA. These data suggest that lipid ADC is dependent on the fatty acid profile of the 430 
feeds and high contents of n-3 LC-PUFA enhance lipid digestibility as these fatty acids 431 
generally have high ADC
(39,40)
. Consistent with this, the ADC for the n-3 LC-PUFA were 432 
high in the present trial and highest in fish fed the TCO diet. Individual fatty acid ADC were 433 
also consistent with previous studies where digestibility decreased with increasing chain 434 
length, but increased with increasing degree of unsaturation
(39,41-42)
. While water temperature 435 
can also impact the ADC of fatty acids, particularly when dietary FO is substituted by VO
(42)
, 436 
the trial was performed at a constant controlled temperature throughout and so differences in 437 
digestibility of individual fatty acids between diets cannot be attributed to water temperature. 438 
Overall, diet TCO had no major negative effects on fatty acid digestibilities and differences 439 
between diets could be attributed to the different fatty acid profile of the feeds. 440 
    Although diet WCO contained the lowest levels of DHA and n-3 LC-PUFA, fish fed this 441 
feed did not show major differences in the contents of DHA in whole fish or tissues 442 
compared to fish fed the COM diet. Anadromous species, such as the salmonids, have the 443 
capability to biosynthesize LC-PUFA, with liver and intestine being the most active 444 
metabolic sites
(43,44)
. In this respect, fish fed WCO showed up-regulation of hepatic fads2d6 445 
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and fad62d5 as well as intestinal elovl5b, which could have contributed in the levels of n-3 446 
LC-PUFA being similar in COM- and WCO-fed fish. Although the COM diet had only a 447 
slightly higher level of DHA compared to WCO (3.7 and 2.7 %, respectively) and much 448 
lower than in TCO (9.0 %) expression levels of desaturases and elongases were similar to that 449 
in fish fed TCO. However, the level of 18:3n-3 was almost 4 times higher in diet WCO than 450 
in the COM diet and it has been suggested that up-regulation of the LC-PUFA biosynthetic 451 
pathway in fish fed VO was induced by the level of dietary precursor (18:3n-3) as well as low 452 
levels of pathway products (e.g. DHA)
(45)
. Therefore, the lower expression of these enzymes 453 
in liver and pyloric caeca of fish fed COM compared to fish fed WCO could be related to the 454 
low dietary level of the substrate 18:3n-3. 455 
    The PCA analysis partly reflected the physiological functions of each tissue. In general 456 
terms, the fatty acid profiles of whole fish and tissues largely reflected that of the diet, 457 
consistent with previous studies in Atlantic salmon
(31,46,47)
. The four distinct quarters of the 458 
plot represent significantly different fatty acid profiles, distinguishing three groups, one per 459 
dietary treatment. The fatty acid vectors representing n-6 and n-3 LC-PUFA have significant 460 
loadings on the “TCO” side of the plot, which is directly related to the diet fatty acid profiles. 461 
This also explains why 18:1n-9 vector is placed towards “COM” as this fatty acid is in high 462 
concentration in rapeseed oil, which constitutes 75 % of the added oil in that diet. Liver fatty 463 
acid profiles from fish fed WCO are located towards the left side of the plot, where fish fed 464 
TCO are placed, which reflects the capacity of liver for the synthesis of LC-PUFA. Head 465 
kidney of fish fed diet TCO tended to cluster on the left panel reflecting differences in head 466 
kidney DHA contents among fish fed the different diets. Although these differences were not 467 
significant in the present trial they were consistent with previous studies in Atlantic salmon, 468 
which showed DHA levels in head kidney reflected the reduced DHA content of VO-based 469 
diets
(48)
. 470 
     The head kidney in fish is an integral tissue of the immune system
(49,50)
, and dietary lipid 471 
and PUFA content are known to influence immune function and thus health status of fish
(51-472 
53)
. In the present study, no differences were observed in the cellular immune functions 473 
evaluated, such as monocyte phagocytic activity or respiratory burst. Previous studies with 474 
sustainable feeds have found contradictory results regarding these immune parameters. While 475 
Atlantic salmon fed diets with different VO (100 % and 50 % substitution of FO, 476 
respectively) did not show altered phagocytic activity nor respiratory burst
(54,55)
 and rainbow 477 
trout (Oncorhynchus mykiss) fed increasing concentrations of ARA showed no differences in 478 
phagocytosis
(56)
, sea bream fed diets containing VO (100 % substitution of FO) showed 479 
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reduced phagocytic activity
(57)
. Differences in the dietary ARA:EPA ratio can alter the 480 
production of immunologically active eicosanoids derived from these fatty acids
(58)
, affecting 481 
signal transduction and regulation of gene expression
(59)
. Despite this, the functional assays 482 
show no negative effects of the oil from transgenic Camelina on the fish immune system. 483 
Furthermore, the expression of several genes related to inflammation and antibacterial 484 
activity evaluated in monocytes isolated from fish after LPS challenge showed no differences 485 
in any of the genes among the dietary treatments at either sampling point. Previously, the 486 
expression of the pro-inflammatory cytokines il1b and tnfa was not changed 12 h after LPS 487 
stimulation in Atlantic salmon after modulation of membrane lipids
(55)
. Therefore, our results 488 
were consistent with replacement of dietary FO by VO in Atlantic salmon feeds having 489 
relatively little influence on inflammatory functions of leukocytes. However, in other teleost 490 
species, dietary VO can have adverse effects on health/immune system through increasing 491 
time to moderate the response up to 7 days after challenge when 70 % of FO was substituted 492 
by VO
(60)
. In this respect, the expression of several inflammatory cytokines as well as the 493 
anti-bactericidal gene cath started to return basal levels only 72 h after challenging Atlantic 494 
salmon monocytes with LPS
(61)
.   495 
      Transcriptomic analyses showed that diet regulated expression of a lower number of 496 
genes in liver than in pyloric caeca, with most of the pathways enriched in liver belonging to 497 
metabolism, which was consistent given the functions of this tissue. One of the genes 498 
commonly regulated by TCO was acsl, which was down-regulated in fish fed TCO compared 499 
to fish fed the other two diets. This gene was also down-regulated in salmon fed a similar 500 
EPA+DHA-containing Camelina oil in a previous trial
(12)
. After LC-PUFA enters a cell, acsl 501 
converts them to fatty acyl-CoAs that can have numerous metabolic fates, including 502 
incorporation into triacylglycerol or phospholipids, or substrates for β-oxidation and protein 503 
acylation
(62)
. Interestingly, a recent study reported up-regulation of acsl3 in hepatopancreas of 504 
grass carp (Ctenopharyngodon idellus) with increasing levels of dietary ARA
(63)
, which is the 505 
opposite trend to that described here, as the TCO feed contained a higher level of ARA than 506 
the other diets. However, previous studies in Atlantic salmon showed no differences in the 507 
expression of acsl in liver between fish fed FO and VO, which had different dietary ARA 508 
contents
(64)
. These authors suggested that this gene may function as a general fatty acid 509 
activator for several lipid metabolism pathways not directly related to β-oxidation. This was 510 
consistent with the present results, given that TCO-fed fish had the lowest lipid content in 511 
body and flesh that, in turn, could be related to enhanced β-oxidation in fish fed this diet. 512 
Among the DEG commonly regulated in fish fed TCO, a transcription factor, pparα, was 513 
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down-regulated in TCO compared to fish fed the other diets. Up-regulation in the expression 514 
of this enzyme, concomitant with the expression of fads2, was observed previously in 515 
rainbow trout after substitution of dietary FO with VO
(65)
.  516 
   The intestine is not only the site of nutrient uptake, but also plays an active role in 517 
metabolism. Indeed, two genes of carbohydrate metabolism were up-regulated in fish fed 518 
TCO compared to fish fed the other diets despite the feeds not differing in carbohydrate 519 
content. In an earlier trial with salmon fed a previous version of transgenic Camelina oil, 520 
intestinal expression of genes of carbohydrate metabolism such as glucose-6-phosphate 521 
isomerase (g6pd) and glycerol kinase 5 (gk5) was up-regulated
(13)
. Previous studies also 522 
reported similar effects, probably reflecting that pathways of lipogenesis, lipolysis, 523 
glycolysis, gluconeogenesis and pentose phosphate shunt are all interrelated in the regulation 524 
of energy homeostasis
(66)
. No genes were found to be commonly regulated in liver and 525 
pyloric caeca in fish fed TCO, probably reflecting the differing functional roles of each 526 
tissue. 527 
   The present study showed that salmon fed the new oil from transgenic Camelina sativa 528 
supplying ~ 24 % n-3 LC-PUFA could accumulate almost double the level of EPA and DHA 529 
in their body and fillet than fish fed a feed reflecting current commercial formulations 530 
containing low levels of marine ingredients. This oil also supported good growth without 531 
apparently compromising fish health and immune response as shown by the ex vivo 532 
macrophage challenge and tissue transcriptomic responses. Although fish were not of harvest 533 
size (final weight, ~400 g), these data suggest that the new oil from a transgenic oilseed crop 534 
has the potential to provide a new generation of salmon feeds that, while maintaining current 535 
levels of sustainability, are also able to restore the EPA+DHA levels in harvest-size (~ 4-5 536 
Kg) farmed salmon to those last seen a decade ago before the development of low marine 537 
feeds. 538 
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Figure Legends 746 
Fig. 1. Principal component analysis (PCA) of fatty acid profiles (percentage of total fatty 747 
acids) of tissues from Atlantic salmon fed the experimental feeds for 12 weeks. Fish fed fish 748 
/rapeseed oil (COM), black; Fish fed wild-type Camelina oil, light grey (WCO); Fish fed 749 
transgenic Camelina oil, dark grey (TCO); filled circle, head kidney; filled square, flesh; 750 
diamond, liver.  751 
Fig. 2. Venn diagram representing genes differentially expressed in liver (A) and pyloric 752 
caeca (B) of Atlantic salmon fed the experimental diets (Welch t-test; p < 0.05, FC > 1.3). 753 
Non-annotated genes and features corresponding to the same gene are not represented. COM, 754 
fish/rapeseed oil feed; TCO, transgenic Camelina oil feed; WCO, wild-type camelina oil 755 
feed. 756 
Fig. 3. Metabolic categories enriched with genes commonly regulated in fish fed transgenic 757 
Camelina oil. Gene networks in liver (A) and pyloric caeca (B) were produced using Enrichr 758 
web-application.  759 
Fig. 4. Expression of genes of the LC-PUFA biosynthesis pathway in liver of Atlantic salmon 760 
as determined by qPCR. Results are normalised expression ratios (means ± SEM; n = 6). 761 
Different superscript letters denote differences among treatments as identified by one-way 762 
ANOVA. COM, fish/rapeseed oil feed; TCO, transgenic camelina oil feed; WCO, wild type 763 
camelina oil feed. elovl2, fatty acyl elongase 2; elovl5a, fatty acyl elongase 5 isoform a; 764 
elovl5b, fatty acyl elongase 5 isoform b; fads2d6, delta-6 fatty acyl desaturase; fads2d5, 765 
delta-5 fatty acyl desaturase.  766 
Fig. 5. Expression of genes of the LC-PUFA biosynthesis pathway in pyloric caeca of 767 
Atlantic salmon as determined by qPCR. Results are normalised expression ratios (means ± 768 
SEM; n = 6). Different superscript letters denote differences among treatments identified by 769 
one-way ANOVA. COM, fish/rapeseed oil feed; TCO, transgenic camelina oil feed; WCO, 770 
wild-type camelina oil feed. Gene abbreviations as described in legend to Fig. 4.  771 
Fig. 6. Expression of genes of inflammation and antibacterial activity in head kidney 772 
monocytes/macrophages of Atlantic salmon at the end of the experimental trial before (0 h), 773 
or 6 h and 24 h after challenging the cells with LPS. Results are expressed as normalised 774 
expression ratios (means ± SEM; n = 6). COM, fish/rapeseed oil feed; TCO, transgenic 775 
camelina oil feed; WCO, wild-type camelina oil feed;  il1b, interleukin 1 beta; tnfα, tumor 776 
 27 
necrosis factor alpha; cox2, cyclooxygenase 2; inos, inducible nitric oxide synthase; cath, 777 
cathelicidin; hepc, hepcidin. 778 
  779 
 28 
Table 1. Formulations, analysed proximate compositions and selected fatty acid profiles of 780 
the experimental diets. 781 
 
COM WCO TCO 
Feed Ingredients (%) 
   Fish Meal 30.00 30.00 30.00 
Soy Protein Concentrate (> 62 %) 10.00 10.00 10.00 
Pea Protein (> 72 %) 10.00 10.00 10.00 
Wheat Gluten 5.00 5.00 5.00 
Maize Gluten 5.00 5.00 5.00 
Wheat 12.95 12.95 12.95 
Fish oil 5.00 0.00 0.00 
Rapeseed oil 15.00 0.00 0.00 
Camelina oil (wild-type) 0.00 20.00 0.00 
Camelina oil (transgenic) 0.00 0.00 20.00 
Mineral and vitamin premixes 2.05 2.05 2.05 
Yttrium oxide 0.05 0.05 0.05 
Analysed composition     
Dry matter (%) 92.6 93.9 92.2 
Protein (%) 45.1 46.4 48.6 
Lipid (%) 23.4 19.7 18.6 
Ash (%) 7.1 7.4 7.6 
Energy (kJ g
-1
) 23.0 22.1 22.4 
Analysed fatty acid profile (%)    
16:0 9.3 8.6 9.5 
Total saturated
* 14.1 14.2 19.9 
18:1n-9 42.4 15.8 7.8 
Total monounsaturated
† 54.2 35.7 18.6 
18:2n-6 15.7 18.2 19.8 
20:4n-6 0.2 0.2 2.2 
Total n-6 PUFA
‡ 16.2 19.9 25.9 
18:3n-3 6.8 22.8 8.7 
20:3n-3 0.1 0.8 0.9 
20:5n-3 3.2 2.4 9.4 
22:5n-3 0.4 0.3 3.9 
22:6n-3 3.7 2.7 9.0 
Total n-3 PUFA
‖
 15.0 29.7 35.2 
Total PUFA
 31.7 50.1 61.5 
Total n-3 LC-PUFA 7.5 5.5 23.9 
COM, fish oil/rapeseed oil feed; WCO, wild-type camelina oil feed; TCO, transgenic 782 
camelina oil feed; LC-PUFA, long-chain polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-783 
3, 22:5n-3, 22:6n-3).
*
Contains 14:0, 18:0 and 20:0; 
†
Contains 16:1n-7, 18:1n-7, 20:1n-11, 784 
20:1n-9, 20:1n-6, 22:1n-11 and 22:1n-9; 
‡
Contains 18:3n-6, 20:2n-6, 20:3n-6 and 22:4n-785 
6. 
‖
Contains 18:4n-3, 20:3n-3 and 20:4n-3.   786 
 29 
Table 2. Growth performance, biometric parameters, and biochemical composition of whole 787 
fish after feeding the experimental diets for 12 weeks. Data are presented as means ± SD (n = 788 
3). 789 
 
COM  WCO  TCO  p value 
 Mean SD  Mean SD  Mean SD   
Final weight (g) 412.2 5.6  397.7 9.2  406.2 18.2  0.447 
Length (cm) 31.4 0.3  31.2 0.2  31.6 0.5  0.400 
Gutted (g) 367.1 14.4  349.5 15.2  365.2 17.6  0.388 
HSI 1.0 0.0  1.0 0.0  1.0 0.1  0.856 
VSI 6.2 0.2  6.1 0.2  5.9 0.2  0.177 
Haematocrit 33.7 0.6  32.4 0.8  33.9 0.8  0.231 
   Whole body composition (% wet weight) 
Crude protein  17.9 0.3  18.2 0.2  18.0 0.6  0.640 
Crude lipid  11.7
a
 0.5  10.9
a
 0.3  9.8
b
 0.2  0.013 
Ash 1.6 0.0  1.6 0.0  1.7 0.0  0.178 
Dry matter 31.5 0.2  32.3 0.6  31.0 0.5  0.270 
 790 
COM, fish oil/rapeseed oil feed; WCO, diet containing wild-type camelina; TCO, transgenic 791 
camelina oil feed; HSI, hepato-somatic index; VSI, viscero-somatic index.  792 
 793 
 794 
  795 
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Table 3. Apparent digestibility coefficients (ADC) of total lipid and individual fatty acids. 796 
Data are presented as means ± SD (n = 3). 797 
  COM  WCO  TCO 
 Mean SD  Mean SD  Mean SD 
Total lipid 94.6
a
 0.3  93.7
a
 0.1  90.7
b
 0.7 
14:0 95.9
a
 0.4  95.0
a
 1.6  92.5
b
 0.1 
15:0 94.6
a
 0.2  92.7
ab
 2.1  89.6
b
 0.8 
16:0 93.9
a
 0.4  92.4
ab
 2.3  89.7
b
 0.8 
18:0 91.8
a
 0.8  89.6
ab
 3.6  85.1
b
 1.5 
Total saturated 93.7
a
 0.5  91.4
ab
 2.8  86.7
b
 1.3 
16:1n-7 97.9
a
 0.5  97.1
ab
 0.9  96.0
b
 0.7 
18:1n-9 98.1
a
 0.4  96.7
a
 0.2  94.4
b
 1.1 
18:1n-7 97.7
a
 0.4  95.8
b
 0.2  95.6
b
 0.6 
20:1n-9 96.5 0.7  97.0 0.2  96.0 0.5 
20:1n-7 95.4 0.7  96.5 0.2  95.0 0.6 
22:1n-11 96.2
a
 0.7  95.2
a
 1.7  91.1
b
 1.9 
22:1n-9 96.2
a
 0.7  94.9
ab
 2.4  91.5
b
 1.2 
Total monoenes 97.9
a
 0.4  96.4
ab
 1.2  94.6
b
 0.6 
18:2n-6 97.8 0.4  97.3 0.5  97.2 0.5 
20:2n-6 90.6
b
 3.4  97.4
a
 0.9  92.5
ab
 1.4 
20:4n-6 97.2
ab
 0.2  95.0
b
 0.0  99.2
a
 1.1 
Total n-6 PUFA 97.7 0.4  97.2 0.5  97.5 0.5 
18:3n-3 98.7 0.3  98.8 0.3  98.3 0.3 
18:4n-3 98.8 0.4  97.5 0.9  99.1 0.3 
20:3n-3 85.7
b
 5.1  97.5
a
 1.0  97.0
a
 0.3 
20:4n-3 96.1
ab
 1.6  91.7
b
 2.5  98.4
a
 0.5 
20:5n-3 98.3
a
 0.3  97.0
b
 0.4  98.5
a
 0.3 
22:5n-3 95.4
b
 1.0  92.7
c
 1.1  98.4
a
 0.4 
22:6n-3 95.6
a
 0.5  92.2
b
 0.7  96.2
a
 0.8 
Total n-3 PUFA 97.7 0.4  97.9 0.4  97.9 0.4 
Total PUFA 98.3 1.3  97.6 0.4  97.7 0.5 
COM, fish oil/rapeseed oil feed; WCO, wild-type camelina oil feed; TCO, transgenic 798 
camelina oil feed; LC-PUFA, long-chain polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-799 
3, 22:5n-3, 22:6n-3). Different superscript letters denote statistically significant differences 800 
between the treatments as determined by one-way ANOVA with Tukey’s and Duncan 801 
comparison test (p < 0.05).  802 
  803 
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Table 4. Lipid contents (percentage of wet weight) and fatty acid compositions (percentage 804 
of total fatty acids) of total lipid of whole body and flesh (muscle) of Atlantic salmon after 805 
feeding the experimental diets for 12 weeks. Data are presented as means ± SD (n = 3). 806 
 807 
 808 
 809 
 810 
 811 
 812 
 813 
 814 
 815 
 816 
 817 
 818 
 819 
 820 
 821 
 822 
 823 
 824 
 825 
 826 
 827 
 828 
 829 
 830 
 831 
COM, fish oil/rapeseed oil feed; WCO, wild-type camelina oil feed; TCO, transgenic 832 
camelina oil feed; LC- PUFA, long-chain polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-833 
3 22:5n-3 and 22:6n-3). Different superscript letters within a row denote significant 834 
differences among diets as determined by one-way ANOVA with Tukey’s comparison test (p 835 
< 0.05). 
*
Contains 14:0, 15:0, 18:0, 20:0 and 22:0; 
†
Contains 16:1n-7, 18:1n-7, 20:1n-9, 836 
22:1n-11, 22:1n-9 and 24:1; 
‡
Contains 20:2n-6 and 20:3n-6; 
‖
Contains 18:4n-3, 20:3n-3 and 837 
20:4n-3.  838 
 
COM   WCO  TCO 
 Mean SD  Mean SD  Mean SD 
Whole body       
Lipid content 11.7
a
 0.5  10.9
a
 0.3  9. 8
b
 0.2   
16:0 10.6 0.3  10.9 0.1  11.0 0.1   
Total saturated
*
 16.1
c
 0.3  17.1
b
 0.2  19.1
a
 0.3   
18:1n-9 38.6
a
 0.7  22.9
b
 0.3  18.5
c
 0.9   
Total monoenes† 52.3a 0.6  40.3b 0.2  31.2c 0.8   
18:2n-6 13.1
c
 0.2  14.4
b
 0.1  16.1
a
 0.5   
20:4n-6 0.3
b
 0.0  0.3
b
 0.0  1.2
a
 0.2   
Total n-6 PUFA‡ 15.1c 0.2  17.0b 0.0  21.1a 0.2   
18:3n-3 4.9
c
 0.1  13.2
a
 0.2  6.5
b
 0.1   
20:5n-3 2.2
b
 0.2  2.1
b
 0.1  5.2
a
 0.3   
22:5n-3 0.9
b
 0.1  0.8
b
 0.0  3.1
a
 0.1   
22:6n-3 6.4
b
 0.6  5.7
b
 0.0  10.1
a
 0.3   
Total n-3 PUFA‖ 16.2c 0.9  25.3b 0.0  28.3a 0.7   
EPA + DHA 8.5
b
 0.8  7.8
b
 0.1  15.3
a
 0.6   
Total n-3 LC-PUFA 8.7 1.2  8.7 1.6  11.2 1.5   
Flesh           
Lipid content 3.9
a
 1.5  2.6
ab
 0.5  2.5
b
 0.6   
16:0 11.7 0.8  11.7 0.3  12.1 0.5   
Total saturated* 17.2
b
 1.0  17.6
b
 0.2  19.7
a
 0.4   
18:1n-9 34.6
a
 1.9  19.1
b
 1.3  14.7
c
 2.0   
Total monoenes† 46.0
a
 2.5  33.4
b
 1.8  24.6
c
 3.3   
18:2n-6 12.2
b
 0.6  12.8
b
 0.3  13.7
a
 0.4   
20:4n-6 0.5
b
 0.1  0.5
b
 0.1  1.7
a
 0.2   
Total n-6 PUFA‡ 14.2
b
 0.6  15.3
b
 0.2  18.2
a
 0.5   
18:3n-3 5.0
c
 0.2  12.7
a
 0.4  6.3
b
 0.4   
20:5n-3 2.9
b
 0.5  3.3
b
 0.4  6.5
a
 0.8   
22:5n-3 1.1
b
 0.1  1.1
b
 0.1  3.5
a
 0.3   
22:6n-3 10.2
b
 0.6  12.4
b
 0.8  17.7
a
 2.0   
Total n-3 PUFA‖ 22.6
b
 2.2  33.8
a
 1.9  37.6
a
 3.0   
EPA + DHA 13.1
b
 2.2  15.6
b
 1.6  24.2
a
 2.6   
Total n-3 LC-PUFA 16.5
b
 0.8  18.7
b
 0.6  29.3
a
 0.8   
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Table 5. Lipid contents (percentage of wet weight) and fatty acid compositions (percentage 839 
of total fatty acids) of total lipid of liver and head kidney of Atlantic salmon after feeding the 840 
experimental diets for 12 weeks. Data presented as means ± SD (n = 3). 841 
 842 
 843 
 844 
 845 
 846 
 847 
 848 
 849 
 850 
 851 
 852 
 853 
 854 
 855 
 856 
 857 
 858 
 859 
 860 
 861 
 862 
 863 
 864 
 865 
 866 
COM, fish oil/rapeseed oil feed; WCO, wild-type camelina oil feed; TCO, transgenic 867 
camelina oil feed; LC- PUFA, long-chain polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-868 
3 22:5n-3 and 22:6n-3). Different superscript letters within a row denote significant 869 
differences among diets as determined by one-way ANOVA with Tukey’s comparison test (p 870 
< 0.05). 
*
Contains 14:0, 15:0, 18:0, 20:0 and 22:0; 
†
Contains 16:1n-7, 18:1n-7, 20:1n-9, 871 
22:1n-11, 22:1n-9 and 24:1; 
‡
Contains 20:2n-6 and 20:3n-6; 
‖
Contains 18:4n-3, 20:3n-3 and 872 
20:4n-3.  873 
 
COM  WCO  TCO 
 Mean SD  Mean SD  Mean SD 
Liver          
Lipid content 4.7 1.0  4.4 0.9   4.1 0.5 
16:0 13.2 1.7  14.0 1.4   15.0 0.9 
Total saturated
*
 19.3
b
 1.9  20.4
ab
 1.3   23.5
a
 1.0 
18:1n-9 24.9
a
 5.5  15.7
b
 2.5   10.4
b
 0.5 
Total monoenes
†
 32.8
a
 6.4  24.3
ab
 3.8   16.1
b
 1.0 
18:2n-6 8.5 1.0  9.1 0.9   7.6 0.5 
20:4n-6 2.5
b
 0.5  2.3
b
 0.3   6.3
a
 0.0 
Total n-6 PUFA
‡
 14.0
b
 0.3  15.0
b
 0.7   17.3
a
 0.4 
18:3n-3 2.6
b
 0.2  6.7
a
 1.1   3.1
b
 0.5 
20:5n-3 5.5
b
 0.7  6.4
b
 0.9   8.2
a
 0.6 
22:5n-3 1.6
b
 0.2  1.6
b
 0.3   3.5
a
 0.4 
22:6n-3 22.8 4.5  22.2 3.3   26.2 1.2 
Total n-3 PUFA
‖
 33.9
b
 5.0  40.3
ab
 2.9   43.1
a
 0.6 
EPA + DHA 28.4 5.1  28.5 3.7   34.4 1.0 
Total n-3 LC-PUFA 30.8
b
 2.1  31.8
ab
 1.4   39.1
a
 0.5 
Head kidney          
Lipid content 5.6 1.1  4.2 0.4   4.1 1.0 
16:0 12.6 0.4  14.0 1.0   14.4 1.6 
Total saturated
*
 18.1
b
 0.6  20.0
ab
 1.1   22.3
a
 2.1 
18:1n-9 32.2
a
 2.2  18.8
b
 1.3   14.2
b
 2.1 
Total monoenes
†
 43.7
a
 2.5  32.0
b
 1.8   23.4
c
 2.8 
18:2n-6 11.3 0.4  11.8 1.0   11.9 1.6 
20:4n-6 1.0
b
 0.2  1.3
b
 0.3   4.2
a
 1.1 
Total n-6 PUFA
‡
 13.7
b
 0.4  14.9
b
 1.1   18.4
a
 0.6 
18:3n-3 4.2
b
 0.1  10.3
a
 1.5   4.9
b
 0.7 
20:5n-3 4.0
b
 0.5  4.8
b
 1.3   7.1
a
 0.5 
22:5n-3 1.1
b
 0.2  1.0
b
 0.1   2.8
a
 0.2 
22:6n-3 11.6 1.5  13.2 2.0   16.5 2.7 
Total n-3 PUFA
‖
 22.8
b
 2.1  32.6
a
 1.8   34.1
a
 2.2 
EPA + DHA 15.7
b
 2.0  18.1
ab
 3.3   23.6
a
 3.2 
Total n-3 LC-PUFA 17.5
b
 0.6  20.2
b
 1.0   27.7
a
 1.2 
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 874 
 875 
Table 6. Summary of liver and pyloric caeca microarray analysis after removing duplicated 876 
probes 877 
 878 
 COM/WCO COM/TCO TCO/WCO 
Liver    
Total no. of probes 44000 
Total no. of DEG 249 312 506 
   Up-regulated genes 169 262 89 
          FC 1.3 – 1.5 58 (34.5 %) 75 (28.6 %) 25 (28.1 %) 
          FC 1.5 – 2.5 88 (52.4 %) 139 (53.1 %) 50 (56.2 %) 
          FC > 2.5 22 (13.1 %) 48 (18.3 %) 14 (15.7 %) 
   Down-regulated genes 80 50 417 
          FC 1.3 – 1.5 23 (28.7 %) 18 (36 %) 157 (37.6 %) 
          FC 1.5 – 2.5 48 (60 %) 28 (56 %) 211 (50.6 %) 
          FC > 2.5 9 (11.3 %) 4 (8 %) 49 (11.8 %) 
Pyloric caeca  
Total no. of probes 44000 
Total no. of DEG 971 804 279 
   Up-regulated genes 918 729 182 
          FC 1.3 – 1.5 518 (56.4 %) 421 (57.8 %) 55 (30.1 %) 
          FC 1.5 – 2.5 263 (28.6 %) 207 (28.4 %) 62 (33.9 %) 
          FC > 2.5 137 (14.9 %) 101 (13.9 %) 66 (36.1 %) 
   Down-regulated genes 53 75 97 
          FC 1.3 – 1.5 5 (9.4 %) 14 (19.8 %) 20 (20.6 %) 
          FC 1.5 – 2.5 24 (45.3 %) 29 (39.2 %) 37 (38.1 %) 
          FC > 2.5 24 (45.3 %) 31 (41.9 %) 40 (41.2 %) 
 879 
COM, fish oil/rapeseed oil feed; WCO, wild-type camelina oil feed; TCO, transgenic 880 
camelina oil feed; DEG, differently expressed gene; FC, fold change. 881 
 882 
  883 
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Table 7. Respiratory burst (absorbance per 1 x 10
5
 cells) and phagocytic activity of 884 
macrophages isolated from experimental fish after 12 weeks of feeding the experimental 885 
diets. 886 
 887 
 COM  WCO  TCO  P 
value 
 Mean SD  Mean SD  Mean SD   
Respiratory burst 0.16 0.04  0.18 0.04  0.15 0.03  0.057 
Phagocytic 
activity 
50.0 5.9  53.3 8.1  47.8 7.6  0.854 
 888 
COM, fish oil/rapeseed oil feed; WCO, wild-type camelina oil feed; TCO, transgenic 889 
camelina oil feed. 890 
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